Preliminary results obtained by a new intraocular lens based on accommodative technology for the treatment of cataract and presbyopia

AbstractPurpose: The aim of this study was to report the clinical results obtained by a new accommodative intraocular lens (AIOL) in terms of visual acuity, refraction, defocus curve, contrast sensitivity and complications incidence for multiple follow‐up phases.Methods: This is a prospective and experimental study composed by patients interested in an AIOL implantation (Lumina, Akkolens) to improve their visual performance. An exhaustive postoperative follow‐up (1 week, 1 month, 3 months, 6 months, 1 year) was performed including the measurements of visual acuity for multiple distances in decimal notation, subjective refraction, accommodative evaluation by defocus curve, contrast sensitivity and a slit lamp and fundus exploration.Results: The study included 42 eyes of 21 patients (mean age of 61.4 ± 10.9 years; 52% females, 48% males). The mean uncorrected distance visual acuity at week was 0.71 ± 0.28, but it improved to 0.85 ± 0.27 a year after the surgery. Similarly, the mean uncorrected near visual acuity improved for 0.48 ± 0.23 at 1 week to 0.60 ± 0.17 at 1 year. The mean equivalent sphere was −0.39 ± 0.60 diopters and the mean corrected distance visual acuity was 1.04 ± 0.16 at 1 year. For a defocus range comprised between 0.00 and −2.00 diopters the mean visual acuity was better than 0.50. The contrast sensitivity assessment showed values higher than 1.10 log units for all frequencies. Capsule opacification with YAG laser requirement was present in 21% of cases (N = 9). At the end of the follow‐up all minimal complications were resolved.Conclusions: The AIOL Lumina Akkolens provided suitable distance vision and functional near vision improving its performance over time. Contrast sensitivity was good being comparable with a monofocal design, but the Lumina IOL shows better near visual performance as revealed in the defocus curve. Significant persistent complications were not observed. These results will be updated with more patients and will be compared with a control group.